Amniotic membrane extract eye drops for ocular surface diseases: use and clinical outcome in real-world practice.
Noelia Sabater-CruzMarc Figueras-RocaMiriam Ferrán-FuertesElba AgustíEva M Martínez-ConesaMaría Luisa Pérez-RodríguezAnna VilarrodonaRicardo-Pedro Casaroli-Maranonull nullPublished in: International ophthalmology (2021)
AMEED administration is a promising mean to treat OSD such as dry eye, persistent epithelial defect and corneal ulcers. Although AMEED may be effective in the treatment of severe DED and persistent epithelial defect or corneal ulcers, conclusions are limited owing to the absence of controlled clinical trials.